GE HealthCare Technologies (GEHC) Long-Term Debt Issuances (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Long-Term Debt Issuances of $1.2 billion for Q1 2026, down 7.1% on a QoQ basis from $1.2 billion in Q4 2025.
GE HealthCare Technologies (GEHC) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 billion (up 290.95% YoY) and the FY2025 annual result came in at $2.7 billion, up 174.77% from the prior year.
- Long-Term Debt Issuances was $1.2 billion for Q1 2026 at GE HealthCare Technologies, down from $1.2 billion in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $8.2 billion in Q4 2022 and bottomed at -$14.0 million in Q4 2023.
- A 5-year average of $1.3 billion and a median of $506.5 million in 2023 frame the typical range for Long-Term Debt Issuances.
- Annual changes were most pronounced in 2023 — Long-Term Debt Issuances slumped 100.17% — and 2025, when it jumped 123900.0%.
- GE HealthCare Technologies' Long-Term Debt Issuances stood at $8.2 billion in 2022, then slumped by 100.17% to -$14.0 million in 2023, then soared by 107.14% to $1.0 million in 2024, then soared by 123900.0% to $1.2 billion in 2025, then fell by 7.1% to $1.2 billion in 2026.
- Business Quant data shows GEHC's Long-Term Debt Issuances at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.71 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.15 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.49 Bn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 993.00 Mn |
| Sep 30, 2024 | 993.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Mar 31, 2023 | 2.00 Bn |
| Mar 31, 2023 | 2.00 Bn |